Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
| Revenue (Most Recent Fiscal Year) | $911.98M |
| Net Income (Most Recent Fiscal Year) | $145.42M |
| PE Ratio (Current Year Earnings Estimate) | 45.26 |
| PE Ratio (Trailing 12 Months) | 15.97 |
| PEG Ratio (Long Term Growth Estimate) | 4.25 |
| Price to Sales Ratio (Trailing 12 Months) | 1.30 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.50 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 14.38 |
| Pre-Tax Margin (Trailing 12 Months) | 6.99% |
| Net Margin (Trailing 12 Months) | 14.33% |
| Return on Equity (Trailing 12 Months) | 10.35% |
| Return on Assets (Trailing 12 Months) | 8.81% |
| Current Ratio (Most Recent Fiscal Quarter) | 6.34 |
| Quick Ratio (Most Recent Fiscal Quarter) | 4.48 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 0.91 |
| Book Value per Share (Most Recent Fiscal Quarter) | $26.88 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.10 |
| Earnings per Share (Most Recent Fiscal Year) | $2.42 |
| Diluted Earnings per Share (Trailing 12 Months) | $4.49 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 28.81M |
| Free Float | 28.18M |
| Market Capitalization | $1.19B |
| Average Volume (Last 20 Days) | 1.17M |
| Beta (Past 60 Months) | 0.73 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.20% |
| Percentage Held By Institutions (Latest 13F Reports) | 94.91% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |